Insider Transactions in Q3 2023 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2023
|
Biogen Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,000,000
-25.37%
|
$0
$0.5 P/Share
|
|
Aug 25
2023
|
David Mark Mc Clung EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,925
-0.89%
|
$0
$0.77 P/Share
|
|
Aug 25
2023
|
Jason D. Fontenot SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,029
-0.74%
|
$0
$0.77 P/Share
|
|
Aug 25
2023
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-1.03%
|
$0
$0.77 P/Share
|
|
Aug 25
2023
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,462
-1.03%
|
$0
$0.77 P/Share
|
|
Aug 25
2023
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,411
-1.7%
|
$0
$0.77 P/Share
|
|
Aug 25
2023
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-0.99%
|
$0
$0.77 P/Share
|
|
Aug 13
2023
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
864
-0.66%
|
$864
$1.08 P/Share
|